Reframing Bummer Trips
Scientific and Cultural Explanations to Adverse Reactions to Psychedelic Drug Use
Bibliographic Data
| ID | 5814147 |
|---|---|
| Authors | Erika Dyck (0000-0002-2745-6695), Chris Elcock (0000-0001-6722-9414) |
| Year | 2020 |
| Volume | 34 |
| Issue | 2 |
| Pages | 271-296 |
| Publication date | 2020-08-20 |
| Open Access | No |
| Type | ARTICLE |
| Venue | The Social History of Alcohol Review (JOURNAL) |
| Journal identifiers | ISSN: 0887-2783 • E-ISSN: 2640-7329 |
| Publisher | University of Chicago Press (PUBLISHER • US) |
| DOI | 10.1086/707512 |
| OpenAlex | W3081352606 |
| Language | EN |
| Citations received | 14 |
| References cited | 8 |
The concept of a bad or bummer trip has been used to capture the imagination of public health advisors and drug regulators, especially for producing warnings against taking drugs that cause physical and psychological harm. Psychedelics emerged in the 1960s public health literature as frequently causing bad trips, with violent and fearful outbursts from users causing harm to themselves and others. The fear and anxiety allegedly generated by a chemical reaction in the body, however, was understood differently by contemporary psychedelic scientists in the 1950s and 1960s. Confronting fear or facing trauma played an important role in psychotherapy, and psychedelic therapists offered an alternative interpretation on the bad trip that imbued it with healthful benefits. This article considers the historical tension surrounding the competing interpretations of bummer trips, probing more deeply into the implications of avoiding fear, trauma, or anxiety in the psychotherapeutic encounter. Ultimately, by considering cases presented at different psychedelic clinics in North America and comparing those with news, personal testimonies, and regulatory outcomes in the United States, we argue that the specter of the bad trip was used strategically to galvanize public support for a prohibition on psychedelics. Moreover, by removing psychedelics from active research, the field of psychotherapy in some jurisdictions moved away from addressing core ideas about fear and trauma through confrontation
Cannabis and Cannabinoid Research · Neurotransmitter Receptor Influence on Behavior · Psychedelics and Drug Studies
Through a glass darkly
Motives for the use of serotonergic psychedelics
Psychedelic-assisted therapy, metacognition, and the problem of integration
Restructuring insight
Cognitive science, dreams and supernatural power in far western North America
Considering the nocebo effect in the psychedelic discourse
Negative mystical experiences
Exploring the therapeutic convergence of meditation, psychedelics, and MDMA
Psychedelic Experiences During the Early Covid-19 Pandemic
Shame, Guilt and Psychedelic Experience
Magic Mushroom Use
Exploring Motivations, Experiences, and Consequences of Psychedelic Use in Aotearoa New Zealand
Enacting Fentanyl Tests Strips for Overdose Prevention
Becoming a Psychedelic User
| Citations per year | 2.8 |
|---|---|
| Citation span | 2021 - 2026 (6) |
| Highly cited | No |